Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. | ||
Founding Date | Founding Date 2001 | Founding Date 2012 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Lund, SE HQ | Locations Houston, US HQ |
Employees | Employees 1555% decrease | Employees 4426% increase |
Valuation ($) | Valuation ($) 59 m | Valuation ($) 1.8 m |
Financial | ||
Net income | Net income (kr51.4m) (FY, 2025) | Net income ($26.9m) (FY, 2024) |
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View company